Alexandra Durr is a consultant in neurogenetics at the genetics department at the University Hospital Salpêtrière in Paris, France. She trained in Germany and France in neurology and genetics. After her medical degree obtained 1992 at the University of Ulm, she joined the neurological department and the INSERM research laboratory on experimental therapy in neurodegenerative disorders in Paris (group leader Alexis Brice). She obtained her PhD in medical genetics in 1998 at the University Denis Diderot Paris VII. Her research interests are phenotypic expression and therapeutic approaches of genetic disorders focused on cerebellar ataxias, spastic paraplegias and inherited conditions of other movement disorders.
Dr Durr opened the first presymptomatic testing facility for late, adult-onset neurogenetic disorders in France and is a member of scientific committees such as the Fondation pour la Recherche Médicale (FRM) and lay organizations devoted to cerebellar ataxias, spastic paraplegias and Huntington’s disease. Since 2003, she has coordinated a European research network, SPATAX, which includes 27 groups that aim to reinforce links between laboratories and clinical centres. She is a member of the executive committee of the Ataxia Study Group (www.ataxia-study-group.net), the Scientific Planning Committee of the EHDN (European Huntington Disease Network, www.euro-hd.net) and the Scientific Advisory Board of INSERM (National Institute of Health and Medical Research, www.inserm.fr).